(Q37876312)

English

Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial

scientific article published on June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial (English)

1 reference

Europe PubMed Central

24 August 2017

0 references

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Dunne MW

1

1 reference

Europe PubMed Central

24 August 2017

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

24 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

24 August 2017

181 Suppl 3

1 reference

Europe PubMed Central

24 August 2017

S572-8

1 reference

Europe PubMed Central

24 August 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Infections caused by Chlamydia pneumoniae strain TWAR

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

The in-vitro antibiotic susceptibility of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Azithromycin-induced block of elementary body formation in Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1086%2F315634

21 January 2018

Identifiers

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37876312&oldid=1744356842"